QSAR study of antiproliferative drug against A549 by GA-MLR and SW-MLR methods

Message:
Article Type:
Research/Original Article (بدون رتبه معتبر)
Abstract:

Quantitative structure-activity relationship (QSAR) is the most extensively used computational methodology for analogue-based design. In this research, QSAR model was used to predict antiproliferative properties of 4-(2-fluorophenoxy) quinoline derivatives against A549(human lung adenocarcinoma). For this purpose, we used the multiple linear regressions (MLR) for the construction of a model to predict drug activity and Stepwise (SW) and genetic algorithm (GA) methods used to build the model. The data were selected from 31 molecules with specific pharmacological activity. They were divided into two sets train and test data. The resulting model was tested using statistical methods such as external test set and cross-validation to ensure its authenticity. The results showed that GA-MLR approach had good predictive power and higher data rates compared with SW-MLR (Q2LOO = 0.877, R2Train =0.933). The results obtained in this study can be used to design drugs with higher performance and pharmacological activity to treat lung cancer.

Language:
English
Published:
Chemical Review and Letters, Volume:2 Issue: 4, Autumn 2019
Pages:
193 to 198
magiran.com/p2687315  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!